Theseus Pharmaceuticals Statistics

Total Valuation

THRX has a market cap or net worth of $177.04 million. The enterprise value is -$24.43 million.

Market Cap	177.04M
Enterprise Value	-24.43M

Important Dates

The last earnings date was Thursday, March 7, 2024, before market open.

Earnings Date	Mar 7, 2024
Ex-Dividend Date	n/a

Share Statistics

THRX has 43.61 million shares outstanding. The number of shares has increased by 13.52% in one year.

Current Share Class	n/a
Shares Outstanding	43.61M
Shares Change (YoY)	+13.52%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	2.56%
Owned by Institutions (%)	93.29%
Float	14.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 29.93, with a Debt / Equity ratio of 0.02.

Current Ratio	29.93
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.80% and return on invested capital (ROIC) is -29.15%.

Return on Equity (ROE)	-24.80%
Return on Assets (ROA)	-23.60%
Return on Capital (ROIC)	-29.15%
Revenue Per Employee	n/a
Profits Per Employee	-$1.49M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.91% in the last 52 weeks. The beta is 3.98, so THRX's price volatility has been higher than the market average.

Beta (5Y)	3.98
52-Week Price Change	-63.91%
50-Day Moving Average	3.96
200-Day Moving Average	4.94
Relative Strength Index (RSI)	59.85
Average Volume (20 Days)	551,970

Short Selling Information

The latest short interest is 401,675, so 0.92% of the outstanding shares have been sold short.

Short Interest	401,675
Short Previous Month	527,466
Short % of Shares Out	0.92%
Short % of Float	2.82%
Short Ratio (days to cover)	0.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-66.52M
Pretax Income	-56.61M
Net Income	-56.61M
EBITDA	-55.98M
EBIT	-56.61M
Earnings Per Share (EPS)	-$1.34

Full Income Statement

Balance Sheet

The company has $205.12 million in cash and $3.66 million in debt, giving a net cash position of $201.47 million or $4.62 per share.

Cash & Cash Equivalents	205.12M
Total Debt	3.66M
Net Cash	201.47M
Net Cash Per Share	$4.62
Equity (Book Value)	224.52M
Book Value Per Share	5.15
Working Capital	202.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$49.63 million and capital expenditures -$72,000, giving a free cash flow of -$49.70 million.

Operating Cash Flow	-49.63M
Capital Expenditures	-72,000
Free Cash Flow	-49.70M
FCF Per Share	-$1.14

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

THRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.52%
Shareholder Yield	-13.52%
Earnings Yield	-31.98%
FCF Yield	-28.08%

Analyst Forecast

The average price target for THRX is $11.75, which is 189.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.75
Price Target Difference	189.41%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3